Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1984 22
1985 11
1986 21
1987 15
1988 14
1989 11
1990 41
1991 38
1992 21
1993 18
1994 27
1995 25
1996 20
1997 21
1998 14
1999 29
2000 71
2001 119
2002 93
2003 85
2004 76
2005 60
2006 43
2007 73
2008 57
2009 35
2010 56
2011 46
2012 19
2013 12
2014 14
2015 31
2016 32
2017 21
2018 15
2019 8
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,236 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma.
Tisi MC, Paolini R, Piazza F, Ravelli E, Tecchio C, Sartori R, Famengo B, D'Amore ESG, Carli G, Perbellini O, Di Bona E, Ruggeri M, Visco C. Tisi MC, et al. Am J Hematol. 2018 Dec;93(12):E386-E389. doi: 10.1002/ajh.25278. Epub 2018 Oct 9. Am J Hematol. 2018. PMID: 30184246 Free article. Clinical Trial. No abstract available.
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
Lonetti A, Cappellini A, Bertaina A, Locatelli F, Pession A, Buontempo F, Evangelisti C, Evangelisti C, Orsini E, Zambonin L, Neri LM, Martelli AM, Chiarini F. Lonetti A, et al. J Hematol Oncol. 2016 Oct 24;9(1):114. doi: 10.1186/s13045-016-0344-4. J Hematol Oncol. 2016. PMID: 27776559 Free PMC article.
1,236 results
Jump to page
Feedback